Cargando…
Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides
Oncogenic types of human papillomaviruses (HPVs) cause cervical cancer and other malignancies in humans. The HPV E6 oncoprotein is considered to be an attractive therapeutic target since its inhibition can lead to the apoptotic cell death of HPV-positive cancer cells. The HPV type 16 (HPV16) E6-bind...
Autores principales: | Stutz, Christina, Reinz, Eileen, Honegger, Anja, Bulkescher, Julia, Schweizer, Johannes, Zanier, Katia, Travé, Gilles, Lohrey, Claudia, Hoppe-Seyler, Karin, Hoppe-Seyler, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495056/ https://www.ncbi.nlm.nih.gov/pubmed/26151636 http://dx.doi.org/10.1371/journal.pone.0132339 |
Ejemplares similares
-
The E6AP Binding Pocket of the HPV16 E6 Oncoprotein Provides a Docking Site for a Small Inhibitory Peptide Unrelated to E6AP, Indicating Druggability of E6
por: Zanier, Katia, et al.
Publicado: (2014) -
Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines
por: Hoppe-Seyler, Karin, et al.
Publicado: (2017) -
Oncogenic Human Papillomaviruses Activate the Tumor-Associated Lens Epithelial-Derived Growth Factor (LEDGF) Gene
por: Leitz, Jenny, et al.
Publicado: (2014) -
Dependence of Intracellular and Exosomal microRNAs on Viral E6/E7 Oncogene Expression in HPV-positive Tumor Cells
por: Honegger, Anja, et al.
Publicado: (2015) -
Transtactin: a universal transmembrane delivery system for Strep-tag II-fused cargos
por: Moosmeier, Markus A, et al.
Publicado: (2010)